For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.
Price · 180d
$15.20
Thesis
Schrödinger combines physics-based molecular simulation with machine learning, monetizing through software licenses and a proprietary drug pipeline. The dual model pairs recurring software revenue with optionality on internal and partnered programs.
Catalysts
- Software revenue growth and customer expansion
- Proprietary pipeline clinical progress
- Collaboration milestones with large pharma